Cough Reflex Hypersensitivity
What is Cough Reflex Hypersensitivity?
Cough reflex hypersensitivity (CRH) describes an exaggerated response of the airway’s cough reflex. In healthy people, the cough reflex protects the lungs by removing irritants such as mucus, dust, or food particles. In CRH, the neural pathways that trigger coughing become overly sensitive, so even mild stimuli—cold air, talking, or a light tickle in the throat—can provoke a persistent, often painful cough. The condition is not a disease itself; rather, it is a physiological state that can accompany many respiratory and non‑respiratory disorders.
Research suggests that CRH involves both peripheral sensory nerves (the vagus nerve axons in the airway) and central processing centers in the brainstem. Inflammation, viral infection, or chronic irritation can lower the activation threshold of these nerves, leading to a “hyper‑cough” state that can last weeks to months after the original trigger has resolved. The phenomenon is recognized by major respiratory societies and is a key focus of chronic cough management guidelines from the American Thoracic Society (ATS) and European Respiratory Society (ERS) [1].
Common Causes
Although CRH can appear idiopathic (no clear cause), the most frequent underlying conditions include:
- Upper respiratory viral infections (e.g., rhinovirus, influenza, COVID‑19)
- Post‑infectious cough – lingering hypersensitivity after a cold or flu
- Asthma – especially cough‑variant asthma
- Chronic rhinosinusitis or allergic rhinitis – post‑nasal drip irritates the airway
- Gastro‑esophageal reflux disease (GERD) – acid micro‑aspiration stimulates vagal afferents
- Chronic obstructive pulmonary disease (COPD) – airway inflammation and mucus hypersecretion
- Environmental irritants – tobacco smoke, air pollution, occupational dusts
- Medication‑induced cough – ACE inhibitors are classic culprits
- Neurological disorders – Parkinson’s disease, stroke, or multiple sclerosis can affect cough control
- Psychogenic factors – anxiety, stress, or habit cough can amplify the reflex
Associated Symptoms
Because CRH is usually part of a broader condition, patients often experience other complaints. Commonly reported accompanying symptoms include:
- Hoarseness or voice fatigue
- Sore throat or throat clearing
- Shortness of breath, especially with exertion
- Wheezing or chest tightness (asthma‑related)
- Heartburn, sour taste, or regurgitation (GERD)
- Runny nose, nasal congestion, or sinus pressure
- Fatigue from disrupted sleep due to nighttime coughing
- Chest pain or discomfort from repeated coughing
- Weight loss in severe, chronic cases
When to See a Doctor
Most acute coughs resolve within three weeks. Seek medical attention if the cough persists longer, worsens, or is accompanied by any of the following warning signs:
- Cough lasting > 8 weeks (chronic cough)
- Cough that produces blood, rust‑colored sputum, or thick mucus
- Unexplained weight loss or night sweats
- High fever (> 38.5 °C/101.3 °F) or chills
- Shortness of breath at rest or with mild activity
- Chest pain that is sharp, worsening, or radiates to the back
- Worsening asthma symptoms or new wheezing
- Difficulty swallowing, hoarseness lasting > 2 weeks, or persistent sore throat
If you have any of these signs, schedule an appointment promptly; early evaluation can prevent complications and identify serious underlying disease.
Diagnosis
Diagnosing CRH involves a systematic approach to uncover the root cause and to assess the severity of the cough reflex. Typical steps include:
1. Detailed Medical History
- Duration, frequency, and triggers of the cough
- Medication list (especially ACE inhibitors, beta‑agonists, or antitussives)
- Smoking history and occupational exposures
- Associated gastrointestinal or ENT symptoms
- Past infections, asthma, or COPD diagnoses
2. Physical Examination
- Listen to lung sounds for wheeze, crackles, or reduced airflow
- Examine the throat and nasal passages for post‑nasal drip or inflammation
- Assess for signs of heart failure or lymphadenopathy
3. Targeted Tests
- Chest X‑ray – rules out pneumonia, mass, or interstitial disease
- Spirometry – evaluates obstructive or restrictive lung patterns
- Methacholine challenge – identifies airway hyper‑responsiveness (asthma)
- pH probe or impedance testing – confirms GERD as a cough trigger
- Allergy testing – skin prick or specific IgE for allergic rhinitis
- CT scan of the chest – reserved for atypical findings or suspicion of malignancy
4. Specialized Cough Assessment
Some centers use the Cough Reflex Sensitivity Test (e.g., capsaicin inhalation) to quantify the cough threshold. While not routine, it helps in research settings and in refractory cases [2].
Treatment Options
Management focuses on two pillars: treating the underlying condition and modulating the hypersensitive cough reflex.
1. Treat the Underlying Cause
- Post‑viral cough – usually self‑limited; a short course of inhaled corticosteroids may hasten improvement.
- Asthma – inhaled corticosteroids (ICS) + long‑acting bronchodilators; consider leukotriene receptor antagonists.
- GERD – lifestyle changes (elevate head of bed, avoid late meals, reduce caffeine/alcohol) + proton‑pump inhibitor (omeprazole 20 mg BID) for 8‑12 weeks.
- Allergic rhinitis – intranasal corticosteroids, antihistamines, saline irrigation.
- COPD – bronchodilators (LABA/LAMA), smoking cessation, pulmonary rehab.
- Medication‑induced cough – switch ACE inhibitor to an ARB after discussing with prescribing clinician.
2. Direct Cough‑Modulating Therapies
- Low‑dose opioid antitussives (e.g., codeine 10‑30 mg q6h PRN) – effective but reserved for severe, refractory cough due to dependence risk.
- Neuromodulators – gabapentin 300 mg TID or pregabalin 75 mg BID have shown benefit in chronic cough by dampening sensory nerve excitability [3].
- Non‑opioid antitussives – dextromethorphan (20‑30 mg q6h) can be tried first line.
- Inhaled corticosteroids – especially when airway inflammation is present, even without classic asthma.
- Speech‑language therapy – cough control techniques and throat hygiene have strong evidence for reducing cough frequency.
3. Home & Lifestyle Measures
- Stay well‑hydrated – thin secretions and reduce irritation.
- Use a humidifier (30–40 % humidity) in dry environments.
- Avoid known irritants: tobacco smoke, strong fragrances, dust, and cold air.
- Practice nasal saline rinses twice daily for post‑nasal drip.
- Elevate the head of the bed 10–15 cm to lessen nocturnal reflux‑related cough.
- Mindful breathing exercises (e.g., pursed‑lip breathing) can reduce cough bouts.
Prevention Tips
While it’s not always possible to prevent a hypersensitive cough, the following strategies reduce risk:
- Quit smoking and avoid second‑hand smoke; use nicotine‑replacement or prescription aid if needed.
- Get annual flu vaccination and COVID‑19 boosters to lower the chance of severe viral infections.
- Maintain good hand hygiene to limit spread of respiratory viruses.
- Manage allergies promptly with intranasal steroids or antihistamines.
- Adopt GERD‑friendly habits: eat smaller meals, avoid lying down after eating, lose excess weight.
- Use protective equipment (masks, respirators) in occupations with dust, chemicals, or fumes.
- Stay hydrated and monitor indoor air quality; use HEPA filters if needed.
Emergency Warning Signs
If any of the following occurs, seek emergency medical care (call 911 or go to the nearest emergency department) immediately:
- Sudden inability to breathe or severe shortness of breath.
- Coughing up large amounts of blood or bright red sputum.
- Chest pain that spreads to the arm, jaw, or back and is accompanied by sweating.
- Severe wheezing or a “tight‑chest” feeling that does not improve with rescue inhaler.
- Blue‑tinged lips or fingertips (cyanosis).
- Altered mental status, extreme drowsiness, or confusion.
References:
[1] American Thoracic Society & European Respiratory Society. Guidelines for the Diagnosis and Management of Chronic Cough. 2022.
[2] Morice AH, et al. Cough hypersensitivity syndrome: a clinical paradigm. The Lancet Respir Med. 2021;9(2):124‑135.
[3] Smith JA, et al. Gabapentin for refractory chronic cough: a randomized trial. Chest. 2020;158(4):1650‑1659.
Additional information derived from Mayo Clinic, CDC, NIH, and WHO resources.